EP1109568A4 - Peptide antigenique code par un autre cadre de lecture ouvert de facteur stimulant la proliferation des macrophages - Google Patents

Peptide antigenique code par un autre cadre de lecture ouvert de facteur stimulant la proliferation des macrophages

Info

Publication number
EP1109568A4
EP1109568A4 EP99968629A EP99968629A EP1109568A4 EP 1109568 A4 EP1109568 A4 EP 1109568A4 EP 99968629 A EP99968629 A EP 99968629A EP 99968629 A EP99968629 A EP 99968629A EP 1109568 A4 EP1109568 A4 EP 1109568A4
Authority
EP
European Patent Office
Prior art keywords
reading frame
open reading
stimulating factor
macrophage colony
antigen peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99968629A
Other languages
German (de)
English (en)
Other versions
EP1109568A1 (fr
Inventor
Michael Probst-Kepper
Den Eynde Benoit Van
Thierry Boon-Falleur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Publication of EP1109568A1 publication Critical patent/EP1109568A1/fr
Publication of EP1109568A4 publication Critical patent/EP1109568A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP99968629A 1998-09-04 1999-09-03 Peptide antigenique code par un autre cadre de lecture ouvert de facteur stimulant la proliferation des macrophages Withdrawn EP1109568A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9907798P 1998-09-04 1998-09-04
US99077P 1998-09-04
PCT/US1999/020344 WO2000013699A1 (fr) 1998-09-04 1999-09-03 Peptide antigenique code par un autre cadre de lecture ouvert de facteur stimulant la proliferation des macrophages

Publications (2)

Publication Number Publication Date
EP1109568A1 EP1109568A1 (fr) 2001-06-27
EP1109568A4 true EP1109568A4 (fr) 2002-05-08

Family

ID=22272533

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99968629A Withdrawn EP1109568A4 (fr) 1998-09-04 1999-09-03 Peptide antigenique code par un autre cadre de lecture ouvert de facteur stimulant la proliferation des macrophages

Country Status (3)

Country Link
EP (1) EP1109568A4 (fr)
AU (1) AU6027399A (fr)
WO (1) WO2000013699A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8021658B2 (en) * 2001-05-25 2011-09-20 Thomas Jefferson University Alternative splice forms of proteins as basis for multiple therapeutic modalities
EP2463299A3 (fr) * 2003-03-05 2012-10-17 Dendreon Corporation Compositions et procédés utilisant des polypeptides à cadre de lecture différents dans le traitement du cancer et de maladies infectieuses
DE102018107224A1 (de) 2018-02-21 2019-08-22 Immatics Biotechnologies Gmbh Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029195A2 (fr) * 1996-02-09 1997-08-14 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Antigene du cancer humain de proteine 1 et 2 apparentee a la tyrosinase et genes le codant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer
JPH03504438A (ja) * 1988-03-30 1991-10-03 アーチ　デベロプメント　コーポレイション アンドロジェンレセプターを含むｄｎａ結合蛋白質

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029195A2 (fr) * 1996-02-09 1997-08-14 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Antigene du cancer humain de proteine 1 et 2 apparentee a la tyrosinase et genes le codant

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MAYRAND S ET AL: "Non-traditionally derived CTL epitopes: exceptions that prove the rules?", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 19, no. 12, December 1998 (1998-12-01), pages 551 - 556, XP004149703, ISSN: 0167-5699 *
RONG-FU WANG ET AL: "UTILIZATION OF AN ALTERNATIVE OPEN READING FRAME OF A NORMAL GENE IN GENERATING A NOVEL HUMAN CANCER ANTIGEN", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 183, no. 3, 1 March 1996 (1996-03-01), pages 1131 - 1140, XP000674490, ISSN: 0022-1007 *
See also references of WO0013699A1 *
WANG R-F ET AL: "HUMAN TUMOR ANTIGENS RECOGNIZED BY T LYMPHOCICYTES: IMPLICATIONS FOR CANCER THERAPY", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL, US, vol. 60, no. 3, 1 September 1996 (1996-09-01), pages 296 - 309, XP000674591, ISSN: 0741-5400 *

Also Published As

Publication number Publication date
AU6027399A (en) 2000-03-27
WO2000013699A1 (fr) 2000-03-16
EP1109568A1 (fr) 2001-06-27

Similar Documents

Publication Publication Date Title
DE19782280T1 (de) Verbesserungen in gepufften Getreidekuchen
DE69232824D1 (de) Dekoder
DE69728945D1 (de) Reed-Solomon Dekoder
FR2721774B1 (fr) Décodeur reed-solomon.
FR2682022B1 (fr) Chaise longue.
ITRM960396A0 (it) Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
EP1030557A4 (fr) Administration de proteines par l'expression des glandes secretoires
IT1275171B (it) Composizioni antiparassitarie in forma di pasta
ITTV940139A0 (it) Struttura perfezionata di zanzariera, del tipo offerta al pubblico in kit di montaggio.
ITBS910078V0 (it) Lettino trasformabile in poltrona
DE69111010D1 (de) Secam Decoder.
DE60328296D1 (de) Heterocarpine, ein pflanzliches protein mit antikrebs eigenschaften
AU6027399A (en) An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor
ITVA910027A1 (it) Decodificatore per rom di tipo nand
IT1242192B (it) Sedile o lettino eliotropico elettricamente motorizzato.
NO20006091D0 (no) Humant protein C-polypeptid
FR2724300B1 (fr) Fauteuil transformable en pouf
ATE185952T1 (de) Verwandelbares sitz- und liegemöbel
FR2713067B1 (fr) Elément de literie formant notamment matelas.
ES1027665Y (es) Mueble tapizado convertible.
ITPR910009U1 (it) Copridivano e copripoltrona.
ITMI940438V0 (it) Divano o e poltrona trasformabili in letto pronto
ES1027824Y (es) Sillon transformable.
KR970016056U (ko) 소파겸용 매트리스
PT1309690E (pt) Mfq-111, uma nova proteina do tipo gtpase humana

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010205

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020327

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/00 A, 7A 61K 38/19 B, 7A 61K 39/00 B, 7G 01N 33/567 B, 7C 07K 14/00 B, 7C 07K 16/24 B, 7C 07K 14/53 B, 7G 01N 33/50 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060119